Fig. 3From: MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathwaymiR-192 activated EMT and PI3K/AKT pathway in NPC. The expressions of E-cadherin, N-cadherin, Vimentin, PI3K, AKT, p-PI3K, and p-AKT were detected in C666-1 cells with miR-192 mimics or inhibitor using Western blot analysisBack to article page